| Senescence as a modulator of oral squamous cell carcinoma development. | |
| | |
MedLine Citation:
|
PMID: 21050803 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Senescence of somatic cells in vitro can occur through the gradual erosion of the chromosomal telomeres following multiple rounds of cell division, or more acutely following cellular stresses connected with oncogene activation, tumour suppressor loss, ageing and migration. These various forms of senescence are associated with the activation of DNA damage checkpoints, the over-expression of p16(INK4A) and the secretion of cytokines, all of which are detected in pre-malignant lesions but muted upon malignant conversion. The various senescence signals are integrated by p16(INK4A) and p53 to produce the permanent cell cycle arrest associated with senescence. Both pRB/p16(INK4A) and p53 are dysfunctional in many cancers, including the most common type of oral cancer, squamous cell carcinoma (OSCC) and other evidence is accumulating in support of the idea that senescence acts as a barrier to tumour development and/or progression. However, senescence of the non-epithelial component of developing human tumours has been shown to enhance growth and invasion of the pre-malignant epithelial component and so senescence may well enhance cancer as well as suppress it depending on the context. |
| | |
Authors:
|
E Kenneth Parkinson |
Related Documents
:
|
2739673 - Evaluation of the reorganization in the high-order structure of dna occurring during ce... 16316623 - Lovastatin-induced rhoa modulation and its effect on senescence in prostate cancer cells. 17185313 - Bystander responses in three-dimensional cultures containing radiolabelled and unlabell... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-11-02 |
Journal Detail:
|
Title: Oral oncology Volume: 46 ISSN: 1368-8375 ISO Abbreviation: Oral Oncol. Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-11-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9709118 Medline TA: Oral Oncol Country: England |
Other Details:
|
Languages: eng Pagination: 840-53 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Centre for Clinical and Diagnostic Oral Sciences, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Turner Street, London E1 2AD, England, UK. e.k.parkinson@qmul.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Grant Support | |
ID/Acronym/Agency:
|
//Biotechnology and Biological Sciences Research Council |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Superselective intra-arterial chemoradiotherapy with docetaxel-nedaplatin for advanced oral cancer.
Next Document: FtsZ-less cell division in archaea and bacteria.